Merrimack Pharmaceuticals, Inc. (MACK) Dividend Details and dates on NASDAQ

Merrimack Pharmaceuticals, Inc. Dividend Stock Review

NASDAQ

Merrimack Pharmaceuticals, Inc. (MACK) Dividend Details and dates on NASDAQ

Merrimack Pharmaceuticals, Inc. Discovers, develops and commercializes drugs for the treatment of immunological and autoimmune diseases and cancer
Sector: Health Technology Biotechnology

Dividend income advisory for MACK
Dividend Yield for MACK
The expected yield for MACK is 0 %, which can be considered at the lower side, after taxation the dividend will return barely more than inflation.

How is MACK priced
MACK has a trailing price to earnings ratio (P/E) of -1.28. The ratio is determined by the performance in the last 12 months. The P/E is negative, Merrimack Pharmaceuticals, Inc. is losing money. The asset does not seem a good fit for long term dividend investing.

Debt to equity of MACK
With the Debt To Equity rate of MACK (0.25) we can conclude that Merrimack Pharmaceuticals, Inc. does not seem to have more liabilities than equity provided by the shareholders. A lower D/E ratio stands for a less risky investment.

Price Prediction for MACK
On average analists predict that MACK will be correctly priced after a -32%. change. Analists are not bulling on the performance of MACK

Upcoming Dividends for MACK
Declared Ex Dividend Date Payment Date Record Date Amount Frequency
2017-05-10 0000-00-00 2017-05-26 0000-00-00 0 USD Other


Dividends in past 12 months MACK
Declared Ex Dividend Date Payment Date Record Date Amount Frequency


Historical Dividends & Cap Growth for MACK
Past 5 Year Capital Gains 0 %
Dividend yield 0 %
Growth including dividends 0%
Latest news for MACK

2019-05-10 Merrimack Pharmaceuticals reports Q1 results No summary available.
Original Article @ Seeking Alpha

2019-03-06 Merrimack Pharmaceuticals reports FY results No summary available.
Original Article @ Seeking Alpha

Dividend Stats For MACK

  • Current Dividend Yield 0%
  • Past Year Payout: 0
  • Next Ex Dividend 0000-00-00
  • Next Payment: 0
  • Our score 32 %

Related dividend stocks